Abstract
Congenital myasthenic syndromes (CMS) are rare genetic disorders that continue to challenge the skills of clinical electrophysiologists, neuromuscular specialists, and general neurologists. Their pathogenesis remained elusive until the early 1990s, when advances in molecular genetics and in vitro neurophysiology of intercostal muscle biopsies provided major insights into disease mechanisms and created new ways to confirm …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
